Approaching global oncology with Ahmed Elzawawy and Wilfred Ngwa

Join the audience for a live webinar at 2 p.m. GMT on 16 November 2022, exploring the need for global approaches to the affordability of cancer treatment

Want to take part in this webinar?

The gap between the required and the available cancer care widened in the last decade for the majority of cancer patients in the world. Ahmed Elzawawy and Wilfred Ngwa will present the need for global approaches, and campaign for the scientific exploration of avenues to improve the affordability of cancer treatment for millions of patients. They do so while considering the interests and incentives of all stakeholders in the real world, including foremost, cancer patients everywhere, but also governments, professional cancer-care providers, health industries, health businesses and the economy.

Want to take part in this webinar?

Ahmed Elzawawy MD PhD is a professor at Suez Canal University, Ismailia, Egypt, and chairman of the Alsoliman Clinical and Radiation Oncology Centre, Port Said, Egypt. His postgraduate studies and the early years of his medical career took place in Paris, France. He serves as chair of the Global Health Catalyst win–win initiative, and chair of the board of directors at the award-winning Global Oncology University (GO-U). He is a former president of the African Organization for Research and Training in Cancer (AORTIC), and president of International Campaign for Establishment and Development of Oncology Centres (ICEDOC). He is on the board of founders for AFROX–H2 (Africa–Oxford–Harvard/Hopkins), Cancer Research Consortium and ecancerforall (World Premier Comprehensive Cancer Center in the Cloud). He contributed to the World Health Organization’s (WHO) cancer strategy for the new millennium, global strategy for radiotherapy and in scientific, educational, and consultancy missions for ICEDOC and the International Agency for Atomic Energy (IAEA) in Africa, Asia, and East Europe. He contributed to the advisory editorial board of many journals e.g. ecancer, Lancet OncologyJCO Global Oncology, the World Journal of Surgical Oncology, and Cambridge Scholars Publishing, UK.

READ MORE:  An Amazon-backed startup demonstrates a novel tractor powered by ammonia

Wilfred Ngwa is director of the Global Health Catalyst, launched at Harvard in 2015 for catalyzing high-impact international collaborations to reduce health disparities in the USA and globally. He is ICTU distinguished professor of public health, associate professor of radiation oncology at Johns Hopkins University and adjunct professor at University of Massachusetts. He is a co-founder with Prof. Ahmed Elzawawy and others of the Global Oncology University (GO-U), and also founding director of the International Phytomedicines Institute. His work at Harvard and Johns Hopkins Medicine has led to development of award-winning tiny drones to target cancer with potential to increase world-wide access to radiotherapy and immunotherapy. Dr Ngwa has won more than 35 prestigious awards/honours from Harvard, the National Institutes of Health, and national and international professional societies and organizations. He chairs the Africa Health and Infrastructure Committee advising the USA government on global health. He has also been appointed by the director of the USA National Institutes of Health to serve in the prestigious role of a charter member for NIH review section from 2022–2028. His has published three books on global health and serves on the editorial board for four leading journals including ASCO’s Journal of Global Health, and Frontiers in Oncology. He serves as a chair of the Lancet Oncology Commission for Sub-Saharan Africa.

READ MORE:  Ghost in the Machine: When Does AI Become Sentient?

About this ebook

Approaching Global Oncology: The win–win model
Editors: Ahmed Elzawawy and Wilfred Ngwa

The Editors and experts who contributed to this book present how there is a need for global approaches and campaign for the scientific exploration of avenues to increase affordability of better value cancer treatment for millions of cancer patients in the world.

This post was originally published on this site

Leave a Reply

Your email address will not be published.